• Elizabeth L Carpenter, Alexandra M Adams, Patrick M McCarthy, Robert C Chick, Holly V Spitzer, Daniel W Nelson, Guy T Clifton, Donnell K Bowen, Robert W Krell, and Timothy J Vreeland.
• Department of Surgery, Brooke Army Medical Center, San Antonio TC, TX 78234, USA.
• Mil Med. 2023 Jul 22; 188 (7-8): e1558e1562e1558-e1562.

IntroductionThe 2020 Commission on Cancer accreditation standards 5.7 and 5.8 address total mesorectal excision for rectal cancer and lymph node sampling for lung cancer. The purpose of this review was to assess our institution's compliance with these operative standards, which will be required in 2022 and 2023, and provide recommendations to other military training facilities seeking to comply with these standards.Materials And MethodsA 2018-2020 single institution chart review was performed of operative and pathology reports. Identified deficits were addressed in meetings with colorectal and thoracic surgery leadership, and cases were followed to reassess compliance.ResultsA total of 12 rectal and 48 lung cancer cases met the inclusion criteria and were examined. Pre-intervention compliance for standards 5.7 and 5.8 was 58% and 35%, respectively, because of inadequate synoptic reporting and lymph node sampling. After intervention, compliance was 100%.ConclusionsOur institution requires changes to comply with new standards, including in areas of documentation and systematic pulmonary lymph node sampling. We provide lessons learned from our own institutional experience, including practical tips and recommendations to achieve compliance. All military training facilities performing lung and rectal oncologic resections should conduct an internal review of applicable cases in preparation for upcoming American College of Surgeons Commission on Cancer site visits.© The Association of Military Surgeons of the United States 2022. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

19 keywords...

hide…